Watanabe Yukihisa S, Yasuda Yoshika, Kojima Yuko, Okada Shino, Motoyama Tomoko, Takahashi Ryo, Oka Mitsuru
a Mie Research Park, Sanwa Kagaku Kenkyusho Co., Ltd. , Mie , Japan .
b Yokohama Laboratory , Mitsubishi Chemical Group Science and Technology Research Center Inc. , Yokohama , Japan .
J Enzyme Inhib Med Chem. 2015 Dec;30(6):981-8. doi: 10.3109/14756366.2014.1002402. Epub 2015 Jul 6.
The single-crystal structure of anagliptin, N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide, was determined. Two independent molecules were held together by intermolecular hydrogen bonds, and the absolute configuration of the 2-cyanopyrrolidine ring delivered from l-prolinamide was confirmed to be S. The interactions of anagliptin with DPP-4 were clarified by the co-crystal structure solved at 2.85 Å resolution. Based on the structure determined by X-ray crystallography, the potency and selectivity of anagliptin were discussed, and an SAR study using anagliptin derivatives was performed.
测定了阿格列汀(N-[2-({2-[(2S)-2-氰基吡咯烷-1-基]-2-氧代乙基}氨基)-2-甲基丙基]-2-甲基吡唑并[1,5-a]嘧啶-6-甲酰胺)的单晶结构。两个独立分子通过分子间氢键结合在一起,并且由L-脯氨酰胺衍生的2-氰基吡咯烷环的绝对构型被确认为S型。通过分辨率为2.85 Å的共晶体结构阐明了阿格列汀与二肽基肽酶-4(DPP-4)的相互作用。基于X射线晶体学确定的结构,讨论了阿格列汀的效价和选择性,并使用阿格列汀衍生物进行了构效关系研究。